01st week of 2021 patent applcation highlights part 10 |
Patent application number | Title | Published |
20210000911 | COMPOSITIONS AND METHODS FOR PROTECTING EPITHELIAL AND BARRIER INTEGRITY | 2021-01-07 |
20210000912 | Compositions And Methods For Prophylaxis Or Treatment Of Pain | 2021-01-07 |
20210000913 | ANIMAL FEED ADDITIVE AND ANIMAL FEED | 2021-01-07 |
20210000914 | ANTIMICROBIAL COMPOSITIONS AND METHODS OF USE THEREOF | 2021-01-07 |
20210000915 | COMPOSITIONS AND METHODS FOR TREATING DIABETES, HYPERTENSION AND HYPERCHOLESTEROLEMIA | 2021-01-07 |
20210000916 | MEDICINE | 2021-01-07 |
20210000917 | METHODS AND COMPOSITION FOR THE TREATMENT OF ALLERGIC ASTHMA | 2021-01-07 |
20210000918 | COMPOSITIONS FOR INHIBITING SPROUT ANGIOGENESIS | 2021-01-07 |
20210000919 | ACTIVATORS OF CXCR3 FOR THE TREATMENT OF ANGIOPATHIES OF THE EYE | 2021-01-07 |
20210000920 | INTRADUCTAL METHODS OF TREATMENT OF BREAST DISORDERS | 2021-01-07 |
20210000921 | METHODS AND COMPOSITIONS FOR MODULATING THYMIC FUNCTION | 2021-01-07 |
20210000922 | DOSING AND USE OF LONG-ACTING CLR/RAMP AGONISTS | 2021-01-07 |
20210000923 | TREATMENT OF SHORT BOWEL SYNDROME PATIENTS WITH COLON-IN-CONTINUITY | 2021-01-07 |
20210000924 | INSULIN-LOADED METAL-ORGANIC FRAMEWORKS | 2021-01-07 |
20210000925 | CLOTTING COMPOSITION | 2021-01-07 |
20210000926 | TREATMENT OF INFECTIONS AND IMMUNE DYSREGULATION IN PATIENTS WITH PRIMARY IMMUNE DEFICIENCIES USING MRNA-CORRECTED AUTOLOGOUS GRANULOCYTES, LYMPHOCYTES AND/OR NATURAL KILLER CELLS | 2021-01-07 |
20210000928 | TREATMENT OF RETINITIS PIGMENTOSA USING ENGINEERED MEGANUCLEASES | 2021-01-07 |
20210000929 | COMPOSITIONS AND METHODS FOR TREATING PARKINSON'S DISEASE | 2021-01-07 |
20210000930 | COMPOSITIONS AND METHODS FOR COUNTERACTING FACTOR XA INHIBITION | 2021-01-07 |
20210000931 | COMPOSITIONS AND METHODS OF USE FOR ALPHA-1 ANTITRYPSIN HAVING NO SIGNIFICANT SERINE PROTEASE INHIBITOR ACTIVITY | 2021-01-07 |
20210000932 | Peptide Conjugated Particles | 2021-01-07 |
20210000933 | TUMOR VACCINE | 2021-01-07 |
20210000934 | POLYMER ADJUVANT | 2021-01-07 |
20210000935 | ACTIVATION OF RESIDENT MEMORY T CELLS FOR CANCER IMMUNOTHERAPY | 2021-01-07 |
20210000937 | Parapoxvirus vectors | 2021-01-07 |
20210000938 | MUTANT OF L1 PROTEIN OF HUMAN PAPILLOMAVIRUS TYPE 16 | 2021-01-07 |
20210000939 | ATTENUATED FLAVIVIRUSES | 2021-01-07 |
20210000940 | ENGINEERED SPIKE PROTEINS OF HANTAVIRUSES AND USES THEREOF | 2021-01-07 |
20210000941 | IMMUNOGENIC COMPOSITION AND VACCINE FOR GENERATING AN IMMUNE RESPONSE TO NOROVIRUS | 2021-01-07 |
20210000942 | VACCINES FORMED BY VIRUS AND ANTIGEN CONJUGATION | 2021-01-07 |
20210000943 | COMPOSITIONS, METHODS AND KITS FOR ELICITING AN IMMUNE RESPONSE | 2021-01-07 |
20210000944 | COMPOSITIONS, METHODS AND KITS FOR ELICITING AN IMMUNE RESPONSE | 2021-01-07 |
20210000945 | VECTOR CO-EXPRESSING VACCINE AND COSTIMULATORY MOLECULES | 2021-01-07 |
20210000946 | INDUCTION AND ENHANCEMENT OF ANTITUMOR IMMUNITY INVOLVING SINDBIS VIRUS VECTORS EXPRESSING IMMUNE CHECKPOINT PROTEINS | 2021-01-07 |
20210000947 | NOVEL MUCOSAL ADJUVANTS AND DELIVERY SYSTEMS | 2021-01-07 |
20210000948 | PD-1 Peptide Inhibitors | 2021-01-07 |
20210000949 | METHODS FOR TREATING OR PREVENTING ASTHMA BY ADMINISTERING AN IL-33 ANTAGONIST | 2021-01-07 |
20210000950 | HUMANIZED CC CHEMOKINE RECEPTOR 4 (CCR4) ANTIBODIES AND METHODS OF USE THEREOF | 2021-01-07 |
20210000951 | COMBINATION THERAPIES | 2021-01-07 |
20210000952 | ANTI-TIGIT ANTIBODIES, ANTI-PVRIG ANTIBODIES AND COMBINATIONS THEREOF | 2021-01-07 |
20210000953 | USE OF IMMUNE CHECKPOINT INHIBITORS IN CENTRAL NERVOUS SYSTEMS NEOPLASMS | 2021-01-07 |
20210000954 | STABLE ANTI-PD-1 ANTIBODY PHARMACEUTICAL PREPARATION AND APPLICATION THEREOF IN MEDICINE | 2021-01-07 |
20210000955 | PHOTODYNAMICALLY ACTIVE ORGANOSILICA NANOPARTICLES AND MEDICAL USES THEREOF | 2021-01-07 |
20210000956 | PHARMACEUTICAL COMPOSITIONS COMPRISING MELOXICAM | 2021-01-07 |
20210000957 | ANTI-CD3 ANTIBODY FORMULATIONS | 2021-01-07 |
20210000958 | METHODS OF INCREASING SOLUBILITY OF POORLY SOLUBLE COMPOUNDS AND METHODS OF MAKING AND USING FORMULATIONS OF SUCH COMPOUND | 2021-01-07 |
20210000959 | Compositions and Methods for Wound Treatment | 2021-01-07 |
20210000960 | STEVIA EXTRACT CONTAINING SELECTED STEVIOL GLYCOSIDES AS FLAVOR, SALTY AND SWEETNESS PROFILE MODIFIER | 2021-01-07 |
20210000961 | COMPOSITION AS AUXILIARY MEANS FOR ORAL MEDICATION | 2021-01-07 |
20210000962 | BONE FRACTURE REPAIR BY TARGETING OF AGENTS THAT PROMOTE BONE HEALING | 2021-01-07 |
20210000963 | ORAL DOSAGE FORM CONTAINING THEOBROMINE-FREE COCOA | 2021-01-07 |
20210000964 | NOVEL FATTY ACIDS AND THEIR USE IN CONJUGATION TO BIOMOLECULES | 2021-01-07 |
20210000965 | ENRICHMENT-TRIGGERED CHEMICAL DELIVERY SYSTEM | 2021-01-07 |
20210000966 | HSP90-TARGETING CONJUGATES AND FORMULATIONS THEREOF | 2021-01-07 |
20210000967 | POLYMER-BASED MACROMOLECULAR PRODRUGS | 2021-01-07 |
20210000968 | ALGINIC ACID DERIVATIVE BONDED TO NONSTEROIDAL ANTI-INFLAMMATORY COMPOUND | 2021-01-07 |
20210000969 | MONOCLONAL ANTIBODY SPECIFICALLY BINDING TO HUMAN PLASMALEMMA VESICLE-ASSOCIATED PROTEIN PV-1, PREPARATION AND USE THEREOF | 2021-01-07 |
20210000970 | Use of Anti-HER2 Antibody-Drug Conjugate in Cancer Treatment | 2021-01-07 |
20210000971 | FUSION PROTEIN COMPRISING GLUTATHIONE-S-TRANSFERASE AND PROTEIN HAVING BINDING AFFINITY TARGET CELL OR TARGET PROTEIN, AND USE THEREOF | 2021-01-07 |
20210000972 | NANOPARTICLES FOR SUSTAINED OPHTHALMIC DRUG DELIVERY AND METHODS OF USE | 2021-01-07 |
20210000973 | RECOMBINANT ADENO-ASSOCIATED VIRUSES ENCODING SERPIN PEPTIDES AND USES THEREOF | 2021-01-07 |
20210000974 | NUCLEIC ACID PRODUCTS AND METHODS OF ADMINISTRATION THEREOF | 2021-01-07 |
20210000975 | MODRNA ENCODING SPHINGOLIPID-METABOLIZING PROTEINS | 2021-01-07 |
20210000976 | EXOSOME TRANSFER OF NUCLEIC ACIDS TO CELLS | 2021-01-07 |
20210000977 | EXPRESSION VECTORS COMPRISING ENGINEERED GENES | 2021-01-07 |
20210000978 | Optimised Coding Sequence and Promoter | 2021-01-07 |
20210000979 | Ophthalmic Compositions, and Ocular Uses Thereof, of Indigo Carmine | 2021-01-07 |
20210000980 | METHOD AND COMPOSITION FOR THE DETECTION OF ARTHROPODS | 2021-01-07 |
20210000981 | CONJUGATED POLYCATIONIC POLYMERS, METHODS OF USING THE SAME AND METHODS OF TREATING AUTOIMMUNE DISEASES, INFECTIOUS DISEASES AND ACUTE RADIATION EXPOSURE | 2021-01-07 |
20210000982 | HYDROGEL COMPRISING MANGANESE, METHODS AND USES THEREOF | 2021-01-07 |
20210000983 | Metal Oxide Nanoparticle-Based T1-T2 Dual-Mode Magnetic Resonance Imaging Contrast Agent | 2021-01-07 |
20210000984 | PREPARATION OF SIZE-CONTROLLED MICROVESICLES | 2021-01-07 |
20210000985 | Gel for Acoustic Coupler, Method for Producing the Same, and Ultrasonic Imaging Method | 2021-01-07 |
20210000986 | INCLUSION COMPLEXES SUITABLE FOR USE AS A HISTOTRIPSY AGENT | 2021-01-07 |
20210000987 | METHOD OF PREPARING A RADIOACTIVE YTTRIUM PHOSPHATE PARTICLE SUSPENSION | 2021-01-07 |
20210000988 | PHARMACEUTICAL COMPOSITION CONTAINING 211AT-LABELED AMINO ACID DERIVATIVE, AND METHOD FOR PRODUCING SAID PHARMACEUTICAL COMPOSITION | 2021-01-07 |
20210000989 | PHOTOSENSITISING COMPOSITION AND USES THEREOF | 2021-01-07 |
20210000990 | STORAGE UNIT FOR A PLUNGER | 2021-01-07 |
20210000991 | TOUCH SCREEN DISPLAY SURFACE SANITIZATION USING ANTIMICROBIAL LIGHT | 2021-01-07 |
20210000992 | SYSTEMS, METHODS, AND DEVICES FOR OZONE SANITIZATION OF CONTINUOUS POSITIVE AIRWAY PRESSURE DEVICES | 2021-01-07 |
20210000993 | MOBILE STERILIZATION APPARATUS AND METHOD FOR USING THE SAME | 2021-01-07 |
20210000994 | USE OF FLUORESCENT POLYMERS IN MARKING COMPOSITIONS FOR THE DIAGNOSTIC DETERMINATION OF CLEANING PERFORMANCE | 2021-01-07 |
20210000995 | FRAGRANCE COMPOSITION FOR MASKING OR DEODORIZING MAL-ODOR | 2021-01-07 |
20210000996 | SPATIAL ENVIRONMENT MANAGEMENT SYSTEM | 2021-01-07 |
20210000997 | Tear-Away Package for Fragrance Impregnated Wafer | 2021-01-07 |
20210000998 | REMOTE SMELL TECHNOLOGY | 2021-01-07 |
20210000999 | AROMA DIFFUSION SYSTEM | 2021-01-07 |
20210001000 | METHOD OF VEHICLE OCCUPANT PROTECTION | 2021-01-07 |
20210001001 | MICROPATTERNED SILICONE OXYGENATING DRESSING FOR CHRONIC WOUNDS | 2021-01-07 |
20210001002 | Composition for hemostasis and container comprising same | 2021-01-07 |
20210001003 | WOUND-TREATING ABSORBENT | 2021-01-07 |
20210001004 | IODINE-LOADED BONE REPAIR MATERIAL AND METHOD FOR PRODUCING THE SAME | 2021-01-07 |
20210001005 | METHOD FOR PRODUCING COLLAGEN VITRIGEL, METHOD FOR PRODUCING PURIFIED COLLAGEN VITRIGEL, AND COLLAGEN VITRIGEL AND PURIFIED COLLAGEN VITRIGEL PRODUCED BY SAID METHODS | 2021-01-07 |
20210001006 | XENOTRANSPLANTATION PRODUCTS AND METHODS | 2021-01-07 |
20210001007 | DECELLULARISED CELL WALL STRUCTURES FROM PLANTS AND FUNGUS AND USE THEREOF AS SCAFFOLD MATERIALS | 2021-01-07 |
20210001008 | METHOD FOR PREPARING INORGANIC NANOPARTICLE-GELATIN CORE-SHELL COMPOSITE PARTICLES | 2021-01-07 |
20210001009 | BIOGUM AND BOTANICAL GUM HYDROGEL BIOINKS FOR THE PHYSIOLOGICAL 3D BIOPRINTING OF TISSUE CONSTRUCTS FOR IN VITRO CULTURE AND TRANSPLANTATION | 2021-01-07 |
20210001010 | UNIAXIALLY-ALIGNED NANOFIBER SCAFFOLDS AND METHODS FOR PRODUCING AND USING SAME | 2021-01-07 |
20210001011 | Oleophilic Lubricated Catheters | 2021-01-07 |
20210001012 | MEDICAL DEVICE AND METHOD FOR PRODUCING MEDICAL DEVICE | 2021-01-07 |